|
ZNF225 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.860600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.687800E-02 |
| Normal-vs-Stage2 |
8.374400E-01 |
| Normal-vs-Stage3 |
6.390100E-02 |
| Normal-vs-Stage4 |
1.179970E-02 |
| Stage1-vs-Stage2 |
8.432100E-02 |
| Stage1-vs-Stage3 |
3.71830000001072E-06 |
| Stage1-vs-Stage4 |
8.17320000012778E-07 |
| Stage2-vs-Stage3 |
2.540800E-01 |
| Stage2-vs-Stage4 |
9.702400E-02 |
| Stage3-vs-Stage4 |
4.090000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.966000E-01 |
| Normal-vs-AfricanAmerican |
3.557800E-01 |
| Normal-vs-Asian |
4.151800E-01 |
| Caucasian-vs-AfricanAmerican |
2.210200E-01 |
| Caucasian-vs-Asian |
3.292600E-01 |
| AfricanAmerican-vs-Asian |
1.935010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.944000E-01 |
| Normal-vs-Female |
7.131600E-01 |
| Male-vs-Female |
6.600600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.121600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.479200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.895600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.496000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.988600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.174800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.392600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.161800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.498620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.724000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.040890E-03 |
| Normal-vs-Grade 2 |
1.521900E-02 |
| Normal-vs-Grade 3 |
2.764600E-01 |
| Normal-vs-Grade 4 |
5.98609999999944E-05 |
| Grade 1-vs-Grade 2 |
1.173440E-01 |
| Grade 1-vs-Grade 3 |
7.393400E-04 |
| Grade 1-vs-Grade 4 |
5.27049999976548E-07 |
| Grade 2-vs-Grade 3 |
6.13010000000136E-05 |
| Grade 2-vs-Grade 4 |
1.17949983113874E-10 |
| Grade 3-vs-Grade 4 |
6.555200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.557810E-03 |
| Normal-vs-ccB subtype |
1.212230E-01 |
| ccA subtype-vs-ccB subtype |
2.31509999948365E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.849800E-01 |
| Normal-vs-N1 |
7.844000E-02 |
| N0-vs-N1 |
6.172000E-02 |
|
|
